Number of the records: 1  

Prognostic significance of number of lymph node metastasis on survival in patients with pathological T3 esophageal carcinoma

  1. SYS0133791
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20170309094006.4
    100
      
    $a 20170306d2017 m y0sloy0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Prognostic significance of number of lymph node metastasis on survival in patients with pathological T3 esophageal carcinoma $f K. Gulben ... [et al.]
    215
      
    $c ilustr., graf, tab.
    320
      
    $a Bibliogr. odkazy
    320
      
    $a Res. angl.
    463
    -1
    $1 001 sllk_un_cat*0133080 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 64, no. 1 (2017), s. 131-135 $1 210 $a Bratislava $c AEPress $d 2017 $1 215 $a s. 1-166
    541
    1-
    $a Prognostický význam počtu metastáz lymfatických uzlín na prežívanie u pacientov s patologickým T3 karcinómom pažeráka $z slo
    606
    1-
    $3 sllk_un_auth*d004938 $a nádory ezofágu $x chirurgia $x terapia $2 mesh
    606
    2-
    $3 sllk_un_auth*d002277 $a karcinóm $x chirurgia $x terapia $2 mesh
    606
    1-
    $3 sllk_un_auth*d008207 $a metastázy lymfatické $2 mesh
    606
    2-
    $3 sllk_un_auth*d016629 $a ezofagektómia $2 mesh
    606
    2-
    $3 sllk_un_auth*d008197 $a lymfadenektómia $2 mesh
    606
    2-
    $3 sllk_un_auth*d017024 $a chemoterapia adjuvantná $2 mesh
    606
    2-
    $3 sllk_un_auth*d018714 $a rádioterapia adjuvantná $2 mesh
    606
    2-
    $3 sllk_un_auth*d018572 $a prežívanie bez choroby $2 mesh
    606
    2-
    $3 sllk_un_auth*d011379 $a prognóza $2 mesh
    610
    2-
    $a faktory prognostické
    701
    -1
    $3 sllk_un_auth*0007983 $a Gulben $b K. $p Ankara Oncology Training and Research Hospital, Department of Surgery, Ankara, Turkey $4 070
    801
    -0
    $a SK $b BA006 $c 20170306 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.